Wave Life Sciences (WVE) announced the appointment of Christopher Wright, MD, PhD, as Chief Medical Officer, CMO. Dr. Wright will join Wave’s executive team and lead global development, including medical, clinical and regulatory functions, to bring the company’s RNA medicines to countless individuals who urgently need them.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WVE:
- Wave Life Sciences: Strategic Advancements and Promising Developments Justify Buy Rating
- Innovative Therapeutics and Promising Clinical Data Drive Buy Rating for Wave Life Sciences
- Wave Life Sciences Reports Q1 2025 Financials and Progress
- Wave Life Sciences: Strong Growth Potential with Upcoming Catalysts and Solid Financial Position
- Wave Life Sciences Reports Q1 2025 Financial Results